FNIP CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. FNIP Gen Silencer sind erhältlich als FNIP CRISPR/Cas9 Knockout Plasmide und FNIP Double Nickase Plasmide. FNIP CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
FNIP CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
FNIP1 CRISPR/Cas9 KO Plasmid (h) | sc-413998 | h | Gene Knockout | GFP | 0 | ||
FNIP1 HDR Plasmid (h) | sc-413998-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FNIP1 Double Nickase Plasmid (h) | sc-413998-NIC | h | Gene Knockout | Puromycin | 0 | ||
FNIP1 Double Nickase Plasmid (h2) | sc-413998-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FNIP1 CRISPR/Cas9 KO Plasmid (m) | sc-432113 | m | Gene Knockout | GFP | 0 | ||
FNIP1 HDR Plasmid (m) | sc-432113-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FNIP1 Double Nickase Plasmid (m) | sc-432113-NIC | m | Gene Knockout | Puromycin | 0 | ||
FNIP1 Double Nickase Plasmid (m2) | sc-432113-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
FNIP2 CRISPR/Cas9 KO Plasmid (h) | sc-409140 | h | Gene Knockout | GFP | 0 | ||
FNIP2 HDR Plasmid (h) | sc-409140-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FNIP2 Double Nickase Plasmid (h) | sc-409140-NIC | h | Gene Knockout | Puromycin | 0 | ||
FNIP2 Double Nickase Plasmid (h2) | sc-409140-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FNIP2 CRISPR/Cas9 KO Plasmid (m) | sc-435963 | m | Gene Knockout | GFP | 0 | ||
FNIP2 HDR Plasmid (m) | sc-435963-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FNIP2 Double Nickase Plasmid (m) | sc-435963-NIC | m | Gene Knockout | Puromycin | 0 | ||
FNIP2 Double Nickase Plasmid (m2) | sc-435963-NIC-2 | m | Gene Knockout | Puromycin | 0 |
FNIP CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
FNIP1 CRISPR Activation Plasmid (h) | sc-413998-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 CRISPR Activation Plasmid (h2) | sc-413998-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 Lentiviral Activation Particles (h) | sc-413998-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 Lentiviral Activation Particles (h2) | sc-413998-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 CRISPR Activation Plasmid (m) | sc-432113-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 CRISPR Activation Plasmid (m2) | sc-432113-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 Lentiviral Activation Particles (m) | sc-432113-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP1 Lentiviral Activation Particles (m2) | sc-432113-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 CRISPR Activation Plasmid (h) | sc-409140-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 CRISPR Activation Plasmid (h2) | sc-409140-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 Lentiviral Activation Particles (h) | sc-409140-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 Lentiviral Activation Particles (h2) | sc-409140-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 CRISPR Activation Plasmid (m) | sc-435963-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 CRISPR Activation Plasmid (m2) | sc-435963-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 Lentiviral Activation Particles (m) | sc-435963-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FNIP2 Lentiviral Activation Particles (m2) | sc-435963-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |